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Abstract
Fibrinogen is an essential part of the blood coagulation cascade and a major component of
the extracellular matrix in mammals. The interface between fibrinogen and bacterial patho-
gens is an important determinant of the outcome of infection. Here, we demonstrate that a
canine host-restricted skin pathogen, Staphylococcus pseudintermedius, produces a cell
wall-associated protein (SpsL) that has evolved the capacity for high strength binding to
canine fibrinogen, with reduced binding to fibrinogen of other mammalian species including
humans. Binding occurs via the surface-expressed N2N3 subdomains, of the SpsL A-
domain, to multiple sites in the fibrinogen α-chain C-domain by a mechanism analogous to
the classical dock, lock, and latch binding model. Host-specific binding is dependent on a
tandem repeat region of the fibrinogen α-chain, a region highly divergent between mam-
mals. Of note, we discovered that the tandem repeat region is also polymorphic in different
canine breeds suggesting a potential influence on canine host susceptibility to S. pseudin-
termedius infection. Importantly, the strong host-specific fibrinogen-binding interaction of
SpsL to canine fibrinogen is essential for bacterial aggregation and biofilm formation, and
promotes resistance to neutrophil phagocytosis, suggesting a key role for the interaction
during pathogenesis. Taken together, we have dissected a bacterial surface protein-ligand
interaction resulting from the co-evolution of host and pathogen that promotes host-specific
innate immune evasion and may contribute to its host-restricted ecology.
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Author summary
Many bacterial pathogens are specialized for a single host-species and rarely cause infec-
tions of other hosts. Our understanding of the bacterial factors underpinning host-specific-
ity are limited. Here we demonstrate that a canine host-restricted bacterial pathogen,
Staphylococcus pseudintermedius, produces a surface protein (SpsL) that has the ability to
preferentially bind to canine fibrinogen with high strength. This host-specific interaction
has evolved via binding to a tandem repeat region of the fibrinogen α-chain which is diver-
gent among mammalian species. Importantly, we found that the strong binding interaction
with canine fibrinogen promotes bacterial aggregation and biofilm formation as well as
inhibiting neutrophil phagocytosis. Our findings reveal the host-adaptive evolution of a key
bacterium-host interaction that promotes evasion of the host immune response.
Introduction
Many bacteria evolve strict mutualistic relationships with their host species with limited capac-
ity to colonize and cause disease in other hosts. In contrast, other bacteria have the ability to
expand into new host-species leading to the emergence of new pathogenic clones. Our under-
standing of the bacterial and host factors that underpin pathogen-host ecology is very limited.
However, bacterial surface proteins are central mediators of host colonization, and tissue tro-
pism and, as such, are likely to play a critical role in determining host ecology [1, 2]. For exam-
ple, the choline-binding protein A, of the major human pathogen Streptococcus pneumoniae,
binds to polymeric immunoglobulin receptor, secretory component, secretory IgA, and factor
H of complement from humans but not from other animal species tested [1]. In addition, the
human host-restricted Streptococccus pyogenes expresses surface-anchored M protein that
binds exclusively to human CD46 mediating binding and invasion of epithelial cells. Adaptive
diversification of bacterial surface proteins can also have a major impact on tissue tropism and
disease manifestation. For example, uropathogenic Escherichia coli virulence has arisen due to
mutations in the fimbrial adhesin FimH, promoting high affinity binding to the urinary epi-
thelium [3]. Similarly, a single non-synonymous mutation in a fibronectin-binding autolysin
of Staphylococcus saprophyticus, associated with a selective sweep, has been linked to the path-
ogenesis of urinary tract infection in humans [4]. Additionally, single amino acid substitutions
in the fibronectin-binding protein A (FnBPA) of Staphylococcus aureus, are associated with
cardiac device infections and bacteremia in humans due to increased binding affinity for fibro-
nectin [5–7].
Fibrinogen is a highly abundant protein in blood and is required for blood coagulation,
thrombosis and host immune defense [8]. This large glycoprotein is composed of three chains,
termed the α-, β-, and γ-chains, that form a dimer of trimers [8]. During coagulation, throm-
bin cleaves the fibrinogen α- and β-chains allowing fibrin formation, with the γ-chain binding
directly to platelets to produce the blood clot [8]. Bacterial pathogens have evolved many
mechanisms to bind to host fibrinogen to disrupt blood coagulation as well as promote host
cell adherence, immune evasion and abscess formation [9, 10]. The importance of this interac-
tion is highlighted by the large number of fibrinogen-binding proteins of bacteria that have
been identified, with S. aureus encoding at least 9 fibrinogen-binding proteins [9–12]. It is
unclear if each of these proteins confer an exclusive function via distinct fibrinogen-binding
sites, or if convergent evolution is driving a high redundancy for fibrinogen-binding. In S.
aureus there are fibrinogen-binding proteins that exhibit host-specificity and those that exhibit
a broader host tropism. In the case of clumping factor B (ClfB) a host-restrictive fibrinogen-
binding phenotype is observed due to the interaction with a sequence unique to the human
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fibrinogen α-chain [13]. Conversely, clumping factor A (ClfA) interacts with fibrinogen from
multiple hosts, such as human, canine, and murine, due to an interaction with the fibrinogen
γ-chain [14]. A single residue substitution of Q407A in the ovine fibrinogen γ-chain is suffi-
cient to eliminate binding of ClfA to ovine fibrinogen [14]. As FnBPA adheres to the same
region in the fibrinogen γ-chain, it is assumed that it exhibits the same host phenotype but this
has not been directly investigated [15].
Staphylococcus pseudintermedius naturally colonizes the nares and perineum of healthy
dogs and is a major cause of canine skin infections, particularly in canine breeds that are genet-
ically pre-disposed to atopic dermatitis including boxers, German shepherds, golden retriev-
ers, Dalmatians, Labrador retrievers, French bulldogs, West Highland white terriers, Jack
Russell terriers, and shar-peis [16–19]. Although S. pseudintermedius occasionally causes zoo-
notic infections of humans via dog bite wounds, it is highly host-restricted and there is limited
evidence for colonization or transmission among non-canine host species such as humans and
cats [17]. Of note, S. pseudintermedius demonstrates a host-specific preference for corneocytes
collected from healthy dogs in comparison to human healthy volunteers [20], suggesting the
existence of bacterial surface factors that promote a canine host-tropism. However, the bacte-
rial factors underpinning the canine host-restricted ecology of S. pseudintermedius are
unknown. Previously, we identified a complement of 18 genes encoding cell wall-associated
proteins of S. pseudintermedius strain ED99 and discovered 2 fibrinogen-binding proteins,
SpsD and SpsL, which exhibited host-dependent variation in fibrinogen-binding after heterol-
ogous expression by Lactococcus lactis [21]. While SpsD was encoded by closely-related species
of staphylococci associated with non-canine host-species, SpsL was specific for S. pseudinter-
medius [21] and was shown to be required for abscess formation in a murine skin infection
model [22]. Previous sequence and structural analysis of SpsL identified a similar domain
architecture to the fibronectin-binding proteins of S. aureus with an amino acid identity of
~27% [21]. In S. pseudintermedius strain ED99, SpsL is a protein of 930 amino acids that con-
tains the typical signatures of a cell wall-associated protein with an N-terminal signal peptide
and C-terminal LPKTG anchor motif [21]. The N-terminal of SpsL consists of an A-domain
with N1, N2, and N3-subdomains that would be predicted to mediate fibrinogen-binding [21].
The C-terminal contains 7 tandem repeats that share 91–100% pairwise identity and 24% pro-
tein identity to the fibronectin-binding repeats of FnBPA [21]. These C-terminal repeats of
SpsL have been demonstrated to confer fibronectin-binding that can mediate internalization
of S. pseudintermedius into canine epithelial cells [23].
Here we dissect the interaction of SpsL with fibrinogen and demonstrate its functional con-
sequences. Using atomic force microscopy (AFM) we quantify the enhanced binding force of
SpsL for canine fibrinogen, which is dependent on a tandem repeat region in the fibrinogen α-
chain that is genetically diverse in mammalian species. Further, we demonstrate that the strong
host-specific interaction with canine fibrinogen is required for SpsL-mediated aggregation and
biofilm formation, and promotes neutrophil opsonophagocytosis suggesting a key role for
SpsL-fibrinogen binding in the pathogenesis and canine host ecology of S. pseudintermedius.
Results
SpsL expressed on the surface of S. pseudintermedius mediates host-specific
binding to fibrinogen
Previously, heterologous expression of SpsL in L. lactis revealed a host-dependent binding to
fibrinogen [21]. In order to investigate this preliminary observation, we examined the capacity
of wild-type S. pseudintermedius strain ED99 to bind to immobilized fibrinogen from different
host species. At mid-exponential growth phase, the highest binding was observed to canine
Bacterial host-specialized fibrinogen-binding
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and human fibrinogen, with very limited binding to bovine and ovine fibrinogen (Fig 1A). A
S. pseudintermedius ED99 mutant deficient in expression of a fibrinogen-binding protein
SpsD (ED99ΔspsD), cultured to early-exponential growth phase, demonstrated binding to
fibrinogen that was equivocal to wild-type ED99 for canine, ovine and human fibrinogen but
reduced for bovine fibrinogen (p<0.001) (Fig 1B). In contrast, a mutant deficient in SpsL
(ED99ΔspsL), cultured to mid-exponential growth phase, exhibited highly reduced binding to
fibrinogen from all host species (p<0.001) (Fig 1C), with complete loss of fibrinogen-binding
by a mutant deficient in both SpsL and SpsD (ED99ΔspsLΔspsD), at both early-exponential
(Fig 1B) and mid-exponential growth phases (Fig 1C). Re-introduction of the deleted spsL
gene restored fibrinogen-binding as did complementation of ED99ΔspsLΔspsD with a plasmid
(pALC2073::spsL) encoding SpsL (Fig 1C and 1D). In summary, these data indicate that S.
pseudintermedius ED99 has host-specific interactions with fibrinogen that are primarily medi-
ated by SpsL. However, these adherence assays do not allow quantification of the strength of
the binding interaction between SpsL and fibrinogen.
SpsL demonstrates an enhanced binding strength for canine fibrinogen
In order to compare the molecular forces driving the binding of SpsL to canine and human
fibrinogen, we used atomic force microscopy (AFM) [24, 25]. Firstly, for single-cell force
Fig 1. SpsL exhibits host-specific binding to fibrinogen. Bacterial adherence assays using crystal violet staining were used to quantify fibrinogen-binding
from 4 host species–bovine, canine, human, and ovine. (A) Adherence of S. pseudintermedius ED99 wild type (WT) when cultured to mid-exponential growth
phase. Data points represent the mean ± SD (n = 3). Differences in binding to fibrinogen was analyzed at 10 μg ml-1 fibrinogen (p� 0.001, two-way ANOVA)
(B) Adherence of WT, ED99ΔspsD, and ED99ΔspsLΔspsD to 20 μg ml-1 fibrinogen when cultured to early-exponential growth phase. (C) Adherence of WT,
ED99ΔspsL, ED99ΔspsLΔspsD, and ED99ΔspsL Rep to 20 μg ml-1 fibrinogen when cultured to mid-exponential growth phase. Error bars represent SD (n = 9).
Differences in fibrinogen-binding was analyzed (p� 0.001, t-test) (D) Adherence of ED99ΔspsLΔspsD expressing SpsL. Data points represent the mean ± SD
(n = 9). Differences in binding to fibrinogen from multiple hosts was analyzed at 10 μg ml-1 (p� 0.001, two-way ANOVA).
https://doi.org/10.1371/journal.ppat.1007816.g001
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spectroscopy (SCFS, Fig 2A), single bacteria were attached onto AFM cantilevers, and force-
distance curves were collected between the cell probes and fibrinogen-coated surfaces (Fig
2A). The adhesion forces obtained for three representative cells interacting with either human
or canine fibrinogen are presented (Fig 2A). While there was substantial variation between
cells, the binding probability was always higher for canine rather than for human fibrinogen
(85% vs 56%; means ± 12 and 28, from a total of n = 1,139 and 1,176 curves). Also, binding
forces were stronger for canine fibrinogen (355 ± 354 pN from n = 228 adhesive curves;
2,077 ± 1,157 pN (n = 388), and 1,024 ± 427 pN (n = 352), for cell #1, cell #2 and cell #3,
respectively), than for human fibrinogen (149 ± 84 pN (n = 85), 744±467 pN (n = 362), and
541±266 pN (n = 216)). Next, we used single-molecule force spectroscopy (SMFS) with
Fig 2. Atomic force microscopy analysis demonstrates increased binding strength of SpsL for canine fibrinogen. (A) Single-cell force spectroscopy (SCFS)
measured the forces between single bacterial cells expressing SpsL A+SD and surfaces coated with either canine (blue) or human (purple) fibrinogen. Shown here are the
adhesion force histograms with representative force curves obtained by recording force-distance curves in PBS for 3 different cells. All curves were obtained using a
contact time of 100 ms, a maximum applied force of 250 pN, and approach and retraction speeds of 1,000 nm.s-1. (B, C) Single-molecule force spectroscopy (SMFS)
captured the localization and binding strength of single adhesins on living bacteria. Adhesion force histograms obtained by recording force curves in PBS across the
surface of single bacteria with either canine (B) or human (C) fibrinogen tips. The insets show adhesion force maps (scale bars: 100 nm, color scales: 3,000 pN) and
representative force curves. Each bright pixel represents the detection of single proteins, no binding is represented by a black pixel and strong binding is represented by a
white pixel. All curves were obtained using a contact time of 100 ms, a maximum applied force of 250 pN, and approach and retraction speeds of 1,000 nm.s-1.
https://doi.org/10.1371/journal.ppat.1007816.g002
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fibrinogen-coated AFM tips to quantify the strength of single bonds (Fig 2B and 2C). Canine
fibrinogen (Fig 2B) always showed very large forces (1,237 ± 754 pN from n = 258 adhesive
curves; 1,554 ± 828 pN (n = 308), and 2,630 ± 1,393 pN (n = 137), for cell #1, cell #2 and cell
#3, respectively). Of note, these high forces are in the range of values reported previously for
the high-affinity “dock, lock and latch” binding of SdrG to fibrinogen [26]. For human fibrino-
gen, these strong forces were also observed but much less frequently (Fig 2C). Taken together
these data are consistent with a high affinity dock, lock and latch-based mechanism for the
binding of SpsL to canine fibrinogen.
The N2N3 subdomains of SpsL expressed on the bacterial cell surface are
required for fibrinogen-binding
To investigate the region of SpsL required for fibrinogen-binding, an array of recombinant
truncates of SpsL were generated and purified from E. coli as described in the Supplemental
Methods section (S1A Fig). From structural and functional studies of related staphylococcal
surface proteins, we predicted that the N2N3 subdomains of SpsL would be sufficient for
fibrinogen-binding [27–29]. However, in ELISA-like assays, none of the purified recombinant
truncates of SpsL exhibited binding to fibrinogen, with all peptides tested demonstrating bind-
ing equivocal to the negative control (fibronectin-binding domain of SpsD) (S1B–S1D Fig). In
contrast, fibronectin-binding could be detected in the SpsL recombinant protein construct
containing a single fibronectin-binding repeat (S1E Fig) [23]. Similarly, full-length or trun-
cated SpsL A-domain fragments expressed and purified from S. pseudintermedius
ED99ΔspsLΔspsD supernatant did not adhere to canine fibrinogen, in contrast to a positive
control of recombinant SpsD N2N3 purified from E. coli (S1F Fig). However, heterologous
overexpression of SpsL on the surface of a fibrinogen-binding deficient S. aureus strain
(SH1000ΔclfAΔclfBΔfnbAΔfnbB) [30] promoted high levels of adherence to canine fibrinogen
(S1G Fig). Taken together, these data suggest that SpsL requires bacterial cell surface attach-
ment to mediate fibrinogen-binding. Accordingly, subsequent experiments employed SpsL
constructs expressed on the surface of S. pseudintermedius ED99.
SpsL fragments representing the A-domain and N2N3 subdomains were expressed on the
surface of the S. pseudintermedius fibrinogen-binding deficient mutant ED99ΔspsLΔspsD (Fig
3A). As reported for other bacterial cell wall-associated proteins, we considered that the C-ter-
minal repeat region may be required to project the fibrinogen-binding domain from the cell
surface, and that a small region of the N1 subdomain may be required for secretion and cell
surface expression [31, 32]. To address this issue, chimeric proteins were generated that
replace the SpsL fibronectin-binding repeats with the ClfA SD repeats (that do not exhibit any
known ligand-binding activity) [33] and that contain a 21 amino acid region of the N1 subdo-
main (N121; 181 VSKEENTQVMQSPQDVEQHVG 201) (Fig 3A). Analysis of the binding of
these constructs to immobilized fibrinogen and expression analysis by Western blot indicated
the requirement for the N121 peptide for cell surface expression, with the N2N3+SD and
N2N3 constructs not expressed on the cell surface (Fig 3B and 3C). Importantly, both the chi-
meric A-domain (A+SD) and N2N3-subdomain (N121+N2N3+SD) proteins exhibited binding
to canine fibrinogen that was equivocal to the full length SpsL protein (Fig 3B). The binding of
the chimeric N121+N2N3+SD protein to fibrinogen from multiple host species indicate that
the SpsL N2N3 subdomains are sufficient for host-specific fibrinogen-binding, with the 21
amino acids of the N1 subdomain required for cell surface expression, (Fig 3D) suggesting that
SpsL mediates ligand-binding in a manner analogous to the dock, lock and latch-binding
mechanism described for other staphylococcal cell wall-associated proteins [34]. To investigate
this further, we modelled the structure of SpsL N2N3 subdomains, based on the crystal
Bacterial host-specialized fibrinogen-binding
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Fig 3. Surface-expressed SpsL N2N3 subdomains mediate host-specific fibrinogen-binding. (A) Schematic of the SpsL cell wall-associated truncates
generated in this study. (B) Adherence of SpsL cell wall-associated truncates to canine fibrinogen using crystal violet staining. (C) Western blot analysis of cell
wall-associated and cell lysate samples of each expression construct using chicken antibody generated against SpsL N2N3. (D) Adherence of SpsL N121+N2N3
+SD to fibrinogen from bovine, canine, human, and ovine hosts using crystal violet staining. Data points represent the mean ± SD (n = 9). (E) Adherence of
SpsLΔlatch in comparison to full length SpsL to fibronectin, canine fibrinogen, and human fibrinogen coated at 20 μg ml-1 using crystal violet staining. The
error bars represent SD (n = 9) (p� 0.001, t-test).
https://doi.org/10.1371/journal.ppat.1007816.g003
Bacterial host-specialized fibrinogen-binding
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structure of ClfA (pdb 1N67) [35]. The structural model predicted classical DE-variant IgG
folds made up of β-sheets typical of staphylococcal fibrinogen-binding proteins (S2A Fig).
From this model we identified a putative latch region, 502 NSASGSG 508, required for the
dock, lock and latch binding mechanism (S2A Fig). Deletion of this putative latch region in a
surface-expressed SpsL construct had no effect on surface expression or fibronectin-binding
but abrogated adherence to both canine and human fibrinogen (p<0.001) (Fig 3E and S2B
Fig). In addition to the AFM data, these results, suggest that the SpsL N2N3-subdomains
expressed on the bacterial surface mediate fibrinogen-binding via a mechanism analogous to
the dock, lock, and latch binding model.
SpsL mediates enhanced binding to canine fibrinogen via a tandem repeat
region of the fibrinogen α-chain
Staphylococcal proteins have evolved the ability to bind fibrinogen through multiple distinct
interactions with different regions of host fibrinogen [13, 14, 36]. Previously it has been identi-
fied that S. pseudintermedius strain 326 is capable of binding to the fibrinogen α-chain with
binding to the β-, and γ-chains not investigated [37]. To identify the binding site of SpsL,
recombinant versions of the α-, β-, and γ-chains of human fibrinogen were expressed in and
purified from E. coli and employed in bacterial binding assays. Both S. pseudintermedius ED99
and ED99ΔspsD demonstrated specific adherence to the human α-chain, but not to the β- or
γ-chains revealing the α-chain as the receptor for SpsL binding (Fig 4A). To further refine the
location of the SpsL binding site, 6 overlapping fragments of the canine fibrinogen α-chain
were synthesized (NCBI reference sequence: XP_532697.2), purified from E. coli, and analyzed
for adherence to ED99ΔspsLΔspsD expressing full length SpsL (Fig 4B and 4C). SpsL demon-
strated binding to two of the overlapping fragments (250–450 and 400–600 amino acids) that
span the α-connector region of fibrinogen containing unordered tandem repeats (residues
P283-S419) (Fig 4B). Purification of equivalent fragments derived from the human α-chain
revealed equivocal binding to the 400–600 fragment but reduced binding to the human 250–
450 fragment (Fig 4D). These data indicate that the canine fibrinogen α-chain contains strong
(250–450) and weaker (400–600) SpsL binding sites while human fibrinogen contains just the
weaker binding site (400–600). To confirm that the canine tandem repeat region is responsible
for the host-specific interaction of SpsL with fibrinogen, we generated chimeric full-length pro-
teins where the tandem repeat region from human and canine fibrinogen α-chains, respectively
(P283-G421), were exchanged. The addition of the canine α-chain tandem repeats provides
stronger binding to the human fibrinogen α-chain and in contrast the addition of the human α-
chain tandem repeats provides weaker binding to the canine fibrinogen α-chain (Fig 4E). As a
control, we examined the binding of ClfB expressed on the surface of SH1000ΔclfAΔclfBΔfn-
bAΔfnbB. ClfB is a S. aureus fibrinogen-binding surface protein that binds specifically to repeat
5 of the human α-chain tandem repeats [13]. The host-specificity of ClfB was confirmed with
specific binding observed to the human 250–450 fragment (S3A Fig), and the canine chimeric
protein containing the human tandem repeat sequence (S3B Fig) but not to the canine 250–450
fragment or the canine alpha chain. These data demonstrate that the tandem repeat region of
the fibrinogen α-chain is responsible for the host-specific interaction of SpsL.
The canine tandem repeat region of the fibrinogen α-chain contains 7 repeats of 18 amino
acids and a partial repeat of 11 amino acids (S3C Fig) [38]. The generation of recombinant
fragments spanning the tandem repeats of the fibrinogen α-chain (S3D Fig), revealed that
SpsL is capable of binding to multiple regions in the canine tandem repeat region (S3E Fig). In
addition, deletion of the whole tandem repeat region, in the canine α-chain, confirmed the
presence of a weaker binding site (Fig 4F), which we localized to the region adjacent to the
Bacterial host-specialized fibrinogen-binding
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tandem repeats (S423-E474) in both canine and human fibrinogen (S3F and S3G Fig). Overall,
these data demonstrate that SpsL mediates binding to multiple locations in the fibrinogen α-
chain, and that the strong canine-specific interaction is dependent on the unique tandem
repeat sequence present in the canine fibrinogen α-chain.
Fig 4. SpsL binds strongly to the tandem repeat region of the canine fibrinogen α-chain. (A) Adherence of ED99ΔspsD to human recombinant fibrinogen chains
using crystal violet staining. (B, D, E, F) Adherence of SpsL expressed in ED99ΔspsLΔspsD to fragments, chimeras, or deletion constructs of the canine and human
fibrinogen α-chains. All data points represent the mean with error bars representing SEM (n = 9). (C) Schematic of the overlapping fragments generated in the canine α-
chain. (G) Schematic of the diversity in the tandem repeat region of the canine fibrinogen α-chain in 11 canine breeds.
https://doi.org/10.1371/journal.ppat.1007816.g004
Bacterial host-specialized fibrinogen-binding
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The fibrinogen α-chain tandem repeat region exhibits canine breed-specific
variation
The number of tandem repeats in the bovine fibrinogen α-chain have been reported to differ
between cattle breeds [39]. To investigate if this is also the case for dogs we investigated pub-
licly available canine sequences of the fibrinogen α-chain but, due to the repetitive nature of
the tandem repeat region, the paired-end short sequence reads were not sufficient to support
assembly and robust analysis. To overcome this, we isolated genomic DNA from 11 different
canine breeds and PCR-amplified DNA specific for the P283-E474 region of the fibrinogen α-
chain, followed by DNA sequencing. Sequence analysis, in comparison to NCBI reference
sequence: XP_532697.2, revealed that the region of weaker binding (S423-E474) is conserved
among the canine breeds examined (S4A Fig). In contrast, the French bulldog and Labrador
retriever exhibited heterozygous alleles that contain an additional repeat unit in the stronger
binding site (Fig 4G). This heterozygous allele, common to both breeds, contains a duplication
of repeat 4 and amino acid substitutions that result in the replacement of repeats 6 and 7 with
repeat 8 (XP_532697.2:p.[S347_S348insTRPGSTGPGSAGTWS;S373N;L394P]) (Fig 4G). The
unique French bulldog allele contains substitutions that convert repeat 5 to repeat 4, and
repeat 7 to repeat 8 (XP_532697.2:p.[S347_T351del;G352R;T361A;L394P]), with a unique
bulldog allele replacing repeat 6 with repeat 8 (XP_532697.2:p.S373N) (Fig 4G). Overall, these
analyses demonstrate that the canine-specific binding site of SpsL in the tandem repeat region
of the canine fibrinogen α-chain has undergone genetic diversification during the evolution of
different breeds of dog.
SpsL promotes bacterial aggregation and biofilm formation in a host-
restricted manner
The evolution of a strong canine-specific fibrinogen-binding interaction for SpsL suggests an
important role in canine host-pathogen interactions. Accordingly, we investigated the impact
of the interaction on phenotypes relevant to pathogenesis. Firstly, we considered if the interac-
tion could promote inhibition of opsonophagocytosis as reported previously for fibrinogen-
binding proteins of S. aureus ClfA and Efb [40, 41]. Accordingly, FITC-labelled bacteria were
opsonized with bovine, canine, human, or ovine fibrinogen or bovine fibronectin and analyzed
for phagocytosis by human neutrophils. As expected, full length SpsL, but not the chimeric A-
domain protein (A+SD), inhibited phagocytosis in the presence of fibronectin (p<0.001) (Fig
5A). However, the ability of SpsL to inhibit neutrophil phagocytosis in the presence of fibrino-
gen was demonstrated to be host-specific with opsonophagocytosis inhibited in the presence
of canine and human fibrinogen (p<0.001) but not in the presence of bovine or ovine fibrino-
gen (Fig 5A).
We next examined the role of SpsL-canine fibrinogen-binding on S. pseudintermedius
aggregation and biofilm formation. The aggregation of S. aureus has been demonstrated to be
important for the development of bloodstream infections [42, 43] and catheter-related infec-
tions [44]. In particular, it has been reported that fibrinogen-dependent S. aureus aggregation
can stimulate the activation of virulence through a quorum-sensing dependent mechanism
[45]. In order to examine the potential role of the canine-specific fibrinogen-binding in S.
pseudintermedius aggregation, we attempted to block binding of S. pseudintermedius to the
canine fibrinogen α-chain by including soluble fibrinogen in a bacterial adherence assay.
Instead of blocking adherence, we found that soluble canine fibrinogen α-chain, but not
human fibrinogen α-chain, supported the formation of surface bound aggregates (Fig 5B).
Deletion of the weaker binding site (S423-E474) in the canine fibrinogen α-chain, had no
effect on bacterial aggregation (Fig 5B). However, deletion of the stronger binding site (the
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tandem repeat region), resulted in complete abrogation of bacterial aggregation (Fig 5B). This
demonstrates that SpsL promotes surface bound bacterial aggregation in a host-restricted
manner. To further investigate the impact of fibrinogen on the aggregation of S. pseudinterme-
dius we performed static biofilm assays in the presence or absence of fibrinogen from different
Fig 5. SpsL promotes evasion of neutrophil phagocytosis, bacterial aggregation and biofilm formation in a host-
specific manner. (A) Differential phagocytosis of FITC-labelled bacteria expressing SpsL or A+SD opsonized with
fibrinogen from bovine, canine, human, or ovine hosts or bovine fibronectin before being opsonized with 10% human
serum. Data is presented as the percentage of cells containing phagocytosed bacteria in comparison to the serum-only
control. Each data point represents the level of phagocytosis from neutrophils isolated from a single donor. Ctrl refers
to bacteria containing an empty plasmid. The bar represents the mean and the error bars represent SD. Differences in
phagocytosis were analyzed between all three bacterial groups for each opsonin (p� 0.05 or p� 0.001, one-way
ANOVA). (B) Adherence of SpsL to canine fibrinogen α-chain in the presence of soluble purified peptides. Data points
represent the mean ± SD (n = 9). (C) Biofilm formation by bacteria expressing SpsL or A+SD on surfaces coated with
bovine, canine, or human fibrinogen. Error bars represent SD (p� 0.001, one-way ANOVA) (n = 4).
https://doi.org/10.1371/journal.ppat.1007816.g005
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host species (Fig 5C). Coating with canine fibrinogen supported enhanced biofilm formation
among bacterial cells expressing SpsL than wells coated with either human or bovine fibrino-
gen demonstrating that the strong interaction of SpsL with canine fibrinogen promotes the ini-
tial attachment stage of biofilm formation (Fig 5C). Overall, these data demonstrate that the
high strength interaction of SpsL with canine fibrinogen promotes bacterial aggregation and
biofilm formation.
In order to investigate if other staphylococcal fibrinogen-binding proteins exhibit similar
host-specificity, we generated constructs expressing chimeric SpsL proteins that contain the
fibrinogen-binding N2N3 subdomains of ClfB or FnBPA but maintain the SpsL promoter, sig-
nal peptide, fibronectin-binding repeats, and cell wall anchor (Fig 6A). The generation of chi-
meric proteins was favored over the expression of native ClfB or FnBPA proteins to limit
variation in cell surface expression. The N2N3 subdomains of these proteins were selected
because of the host-restriction of ClfB to human fibrinogen α-chain and the similar domain
architecture of SpsL and FnBPA. As expected from our previous analysis, SpsL showed similar
binding to both canine and human fibrinogen (Fig 6B). However, the high strength interaction
of SpsL with canine fibrinogen is essential for bacterial aggregation (Fig 6C) and biofilm for-
mation (Fig 6H). SpsL-ClfBN2N3 demonstrated a similar binding curve to SpsL but exhibited
specific binding to human fibrinogen (Fig 6D) as previously predicted [13]. This human
fibrinogen-binding was not sufficient to mediate bacterial aggregation (Fig 6E) or biofilm for-
mation (Fig 6H) demonstrating that not all staphylococcal fibrinogen-binding proteins are
capable of mediating these infection-related phenotypes. In contrast, SpsL-FnBPAN2N3 exhib-
ited a binding pattern predicted from an interaction with the fibrinogen γ-chain with equivo-
cal binding to bovine, canine, and human fibrinogen and reduced ovine fibrinogen-binding
(Fig 6F). SpsL-FnBPAN2N3 is capable of mediating bacterial aggregation (Fig 6G) and biofilm
formation (Fig 6H) in the presence of fibrinogen from all hosts tested suggesting that FnBPA
does not have a host-restricted tropism. From this comparative analysis we can conclude that
SpsL is unique in promoting bacterial aggregation and biofilm formation in a manner that cor-
responds to the host-restricted ecology of S. pseudintermedius.
Discussion
The factors underpinning bacterial host-tropism are not well understood but often involve
surface proteins mediating interactions with host cells and the extracellular matrix [1]. The
genus Staphylococcus includes species such as S. aureus which have a multi-host tropism with
the capacity to switch between different host species. In contrast, some species such as S. pseu-
dintermedius are highly host-restricted and although S. pseudintermedius can occasionally
cause zoonotic infections of humans (typically through dog bite wounds), the capacity to
spread in human populations has not been reported. The bacterial factors underpinning the
host-restricted ecology of S. pseudintermedius are unknown. Previously, we demonstrated that
SpsL contributed to abscess formation in a murine model of subcutaneous infection indicating
that it is a virulence factor during the pathogenesis of skin infection [22]. The poor binding of
SpsL to murine fibrinogen suggests that this effect is not mediated by the interaction of SpsL
with murine fibrinogen [22]. Here we demonstrate that SpsL mediates high strength binding
to canine fibrinogen in a host-specific manner and that this host-adaptation conferred the abil-
ity to mediate bacterial aggregation and biofilm formation. The role of SpsL-fibrinogen bind-
ing in canine pathogenesis cannot be formally tested in vivo by experimental infections of dogs
in the UK due to ethical constraints. However, our ex vivo binding and cellular infection data
reveal multiple pathogenic traits that depend on the host-specific interaction of SpsL and
canine fibrinogen, suggesting a key role in the host ecology of S. pseudintermedius.
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Fig 6. SpsL promotes bacterial aggregation and biofilm formation in a host-restricted manner. (A) Schematic of the SpsL
chimeric cell wall-associated truncates generated. Bacterial adherence assays of full length SpsL (B), chimeric SpsL-ClfBN2N3 (D),
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Cell surface proteins of S. aureus have been reported to contribute to tissue or disease tro-
pism in humans. For example, the fibrinogen- and loricrin-binding protein, ClfB, exhibits
greater adherence to skin corneocytes taken from atopic dermatitis patients with low levels of
natural moisturizing factor suggesting a role in niche adaptation [46, 47]. ClfB interacts with
the human tandem repeat region of the fibrinogen α-chain [13] but unlike SpsL, ClfB binds to
a single site; namely repeat unit 5, and exclusively binds to human fibrinogen [13]. In addition
to ClfB, the bone sialoprotein-binding protein (Bbp) and the extracellular fibrinogen-binding
protein (Efb) also bind to the fibrinogen α-chain via distinct RGD-integrin-binding sites
inhibiting thrombin-induced coagulation and platelet aggregation, respectively [36, 48]. In
contrast, SpsL interacts with multiple sites in the canine fibrinogen α-chain; namely within the
tandem repeats and their flanking regions, (Fig 4). Similarly, the serine-rich repeat glycopro-
teins of Streptococcus agalactiae, Srr1 and Srr2, bind to repeat units 6, 7, and 8 of the tandem
repeat region of the human fibrinogen α-chain via a variation of the dock, lock, and latch bind-
ing mechanism, with Srr2 displaying a stronger binding affinity than Srr1 [49]. The enhanced
binding affinity of Srr2 was linked with increased adherence to endothelial cells, which may be
important for Group B Streptococcus-associated meningitis [49]. The ability of the Srr and
SpsL proteins to adhere to more than one site in the tandem repeat region of the fibrinogen
α-chain may have evolved as a mechanism for overcoming extant genetic diversity in this
region between individuals within a host species as observed in the current study for SpsL (Fig
4G) [39, 50].
We were unable to detect binding of soluble SpsL proteins to canine fibrinogen by ELISA
suggesting that immobilization and surface presentation is essential for SpsL functionality,
even when full length SpsL is expressed as a recombinant protein (S1 Fig). To address this, we
utilized AFM, demonstrating that bacterial surface-associated SpsL binds to fibrinogen via
extremely strong binding forces (around 2000 pN) that are in the range of the strength mea-
sured for the dock, lock and latch interaction between fibrinogen and the structurally-related
SdrG and ClfA [26, 51]. Dock, lock and latch forces have been shown to originate from hydro-
gen bonds between the ligand peptide backbone and the adhesin [52, 53], and are activated by
mechanical tension, as observed with catch bonds [54]. Of note, ClfB has much greater affinity
for loricrin when expressed on the bacterial cell surface rather than as a recombinant protein
with the C-terminal stalk enhancing binding affinity [25]. A similar mechanism may be
required for SpsL adherence to fibrinogen with the C-terminal repeat domain enhancing the
ligand-binding affinity of the N2N3 subdomains. It is increasingly being recognized that analy-
sis of protein-protein interactions on the bacterial cell surface is more physiologically relevant
than testing the interaction of recombinant polypeptides [25, 55].
Our data reveal that the high strength canine-specific binding of SpsL facilitates several vir-
ulence phenotypes not previously reported for S. pseudintermedius including surface-bound
bacterial aggregation. When S. aureus forms fibrinogen-dependent aggregates, agr-mediated
quorum sensing is activated leading to the up-regulation of virulence gene expression [45].
Consequently, the inhibition of S. aureus aggregation in vivo has been linked with decreases in
mortality from sepsis and protection from lethal lung injury [43, 56]. We also discovered that
SpsL facilitates fibrinogen-dependent biofilm formation, a phenotype not previously reported
for S. pseudintermedius. Such fibrinogen-dependent biofilms are observed in S. aureus strains
or chimeric SpsL-FnBPAN2N3 (F) to fibrinogen from bovine, canine, human, and ovine. Data points represent the mean ± SD
(n = 9). Adherence of full length SpsL (C), chimeric SpsL-ClfBN2N3 (E), or chimeric SpsL-FnBPAN2N3 (G) to canine fibrinogen
or human fibrinogen in the presence of soluble canine or human fibrinogen. Data points represent the mean ± SD (n = 9). (H)
Biofilm formation by bacteria expressing SpsL, chimeric SpsL-ClfBN2N3, or chimeric SpsL-FnBPAN2N3 on surfaces coated with
bovine, canine, or human fibrinogen. Error bars represent SD (p� 0.001, one-way ANOVA) (n = 3).
https://doi.org/10.1371/journal.ppat.1007816.g006
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isolated from skin infections [57], a phenomenon implicated in indwelling medical device
infections [58]. In this regard, inhibition of fibrin formation reduced the development of S.
aureus biofilms in a murine catheter infection model [58], and molecules targeting SpsL could
be beneficial in preventing canine indwelling device infections caused by S. pseudintermedius.
Finally, we have demonstrated that SpsL binding to soluble fibrinogen inhibits neutrophil
phagocytosis, suggesting a role for SpsL in innate immune evasion. Taken together, we have
dissected the host-dependent binding of a bacterial surface protein and demonstrated its
importance for multiple pathogenic traits, providing new insights into the host-specific ecol-
ogy of a major bacterial pathogen.
Materials and methods
Ethics statement
Chicken immunization was performed using unembryonated hen’s eggs at the Scottish
national blood transfusion service (Pentland Science Park, Midlothian, UK). The procedures
performed were carried out under the authority of the UK Home Office Project License PPL
60/4165 and Animals (Scientific Procedures) Act 1986 regulations.
Human venous blood was taken from consenting adult healthy volunteers in accordance
with a human subject protocol approved by the national research ethics service (NRES) com-
mittee London City and East under the research ethics committee reference 13/LO/1537. Pas-
sive volunteer recruitment was conducted at the Roslin Institute (University of Edinburgh).
Written consent was taken from each volunteer before blood collection and after an outline of
the risks was provided. All blood collection samples were anonymized.
Bacterial strains and culture conditions
The bacterial strains and plasmids used in this study are listed in S1 Table. S. pseudintermedius
and S. aureus strains were routinely cultured in Brain Heart Infusion broth at 37˚C with shaking
and supplemented with 10 μg ml-1 chloramphenicol as required. E. coli strains were cultured in
Luria broth at 37˚C with shaking supplemented with 100 μg ml-1 ampicillin, 15 μg ml-1 tetracy-
cline, or 25 μg ml-1 kanamycin as required.
Source of extracellular matrix proteins
Fibrinogen isolated from bovine, human, and ovine plasma (Sigma-Aldrich) and bovine fibro-
nectin (EMD Millipore) was sourced commercially. Canine fibrinogen was purified from Bea-
gle sodium citrate whole blood (Lampire Biological Products) using a previously described
method [59]. All fibrinogen samples were purified to remove contaminating fibronectin using
Gelatin-Sepharose 4B (GE Healthcare). Depletion of fibronectin was confirmed by Western
blot analysis using 1 μg ml-1 rabbit anti-fibronectin IgG (abcam) and 0.2 μg ml-1 goat anti-rab-
bit IgG-HRP (abcam).
Bacterial adherence assay
Solid phase adherence assays were performed using S. pseudintermedius and S. aureus strains
expressing pALC2073 or pCU1 constructs cultured to an OD600nm of 0.6 and induced for pro-
tein expression with 3 μg ml-1 anhydrotetracycline for 2 h. Cells were washed and suspended
in PBS to OD600nm of 1.0. Wells were coated overnight at 4˚C with fibrinogen from multiple
hosts or recombinant α-chain fragments in a 96-well MaxiSorp plate (Nunc). After blocking
with 8% (w/v) milk-PBS, bacteria were applied to the wells for 2 h at 37˚C. After washing,
adherent cells were fixed with 25% (v/v) formaldehyde (Sigma) for 30 min and stained with
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0.5% (v/v) crystal violet (Sigma) for 3 min. The cell-associated stain was solubilized with 5%
acetic acid (v/v) and analyzed using a Synergy HT plate reader (BioTek) at 590 nm
wavelength.
For aggregation experiments, the same procedure was followed as stated above with the
addition of either soluble fibrinogen or recombinant fibrinogen α-chain to the bacteria using
two-fold serial dilution and then incubation for 2 h at 37˚C.
Cloning of expression constructs
The primers used in this study are listed in S2 Table. Initial expression constructs of the
human and canine fibrinogen α-chains were synthesized by Integrated Design Technologies
(IDT) using the DNA sequence of a female Boxer (NCBI reference sequence: XP_532697.2) as
highlighted in S1 Table. For typical restriction-ligation cloning procedures, the region of inter-
est was amplified (PfuUltra II Fusion HS Polymerase—Agilent) and blunt cloned into pSC-B
using the StrataClone Blunt PCR Cloning Kit (Agilent). Restriction digestion of the plasmid of
interest (pQE30, pT7, or pALC2073) and the blunt cloned PCR product was performed at
37˚C for at least 2 h and purified using the Monarch Gel Extraction Kit (NEB). All digested
plasmids were treated with Antarctic Phosphatase (NEB) before overnight ligation with T4
DNA Ligase (NEB) at a 3:1 molar ratio of insert:plasmid. Dialysis of the 20 μl ligation reactions
was performed using 0.025 μm filter circular discs (Millipore) before electroporation into the
appropriate E. coli strain–DC10B [60], DH5α (Invitrogen), or XL-1 Blue (Agilent). All plasmid
constructs were verified by Sanger sequencing (Edinburgh Genomics, University of Edin-
burgh) before transformation into E. coli BL21 DE3 (Invitrogen), or appropriate S. pseudinter-
medius strain.
Some expression constructs were also produced using sequence ligase independent cloning
(SLIC) as described previously [61]. Briefly, primers were designed to amplify the gene of
interest as well as sequence complementation to the expression plasmid. Primers were also
designed to amplify the plasmid of interest, pQE30, pALC2073 or pCT using Platinum PCR
Supermix (Invitrogen) or PfuUltra II Fusion HS Polymerase (Agilent). All PCR products were
purified using Monarch PCR & DNA Cleanup kit or Monarch Gel Extraction kit (NEB). T4
DNA Polymerase (NEB) was used to generate DNA overhangs on both the insert and plasmid
PCRs with step-wise temperature increments used to anneal the complementary DNA
sequences. The heat annealed constructs were electro-transformed into E. coli DC10B [60] or
DH5α (Invitrogen) and verified using Sanger sequencing (Edinburgh Genomics, University of
Edinburgh).
Preparation of Staphylococcus competent cells and electro-transformation
S. pseudintermedius and S. aureus competent cells were produced using a method outlined pre-
viously [60]. Plasmids for electroporation were concentrated to 1 μg μl-1 using Pellet Paint co-
precipitant (Novagen) and 5 μg used for the electro-transformation as previously described
[23].
Recombinant protein induction and purification
Recombinant hexa-Histidine-tagged proteins expressed in E. coli were cultured to OD600nm of
0.6 and induced using 1 mM IPTG at either 37˚C for 4 h or 16˚C overnight. Recombinant α-
chain proteins were purified under denaturing conditions (8M urea, 100 mM monosodium
phosphate, 10 mM Tris-HCl) using Ni-NTA agarose (Invitrogen) and gravity flow columns
(Bio-Rad). Bacterial lysis was performed in pH 8.0 binding buffer at room temperature with
tilting for at least 1 h. Lysates were pelleted at 16000 x g for 20 min and the supernatant filter
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sterilized. Lysates were tilted at room temperature with conditioned Ni-NTA agarose for 1 h.
The column was washed with pH 6.3 wash buffer and the protein eluted with pH 4.5 elution
buffer. After analysis by 4–20% Mini-PROTEAN TGX precast gel (Bio-Rad), protein quantifi-
cation was performed using a BCA assay (Novagen).
Release of surface proteins from S. pseudintermedius
S. pseudintermedius cells were cultured to exponential phase (OD600nm of 0.4–0.6). Cells were
washed with PBS and suspended in lysis buffer (50 mM Tris-HCl, 20 mM MgCl2, pH 7.5) sup-
plemented with 30% (w/v) raffinose and cOmplete protease inhibitor (Roche). Cell wall pro-
teins were solubilized by incubation with 400 μg ml-1 lysostaphin at 37˚C for 20 min.
Supernatant samples were collected after protoplast recovery by centrifugation at 6000 x g for
20 min. The production of cell lysate samples was generated by lysing cell pellets in PBS on the
One-Shot cell disruptor (Constant Systems) with 2 passes at 40 Kpsi.
Generation of anti-SpsL N2N3 IgY Antibody
Recombinant His-tag SpsL N2N3 protein was used as antigen for chicken immunization and
antibody generation at the Scottish national blood transfusion service (Pentland Science Park).
The Eggspress IgY purification kit (Gallus Immunotech) was used to purify antibody from egg
yolk. Further purification of the antibody was performed using CNBr-activated Sepharose 4B
(GE Healthcare). This antibody was used in Western blot analysis to detect the expression of
SpsL using 1 μg ml-1 chicken anti-SpsL N2N3 IgY and 0.5 μg ml-1 F(ab’)2 rabbit anti-chicken
IgG-HRP (Bethyl Laboratories).
Atomic force microscopy
Functionalization of substrates with fibrinogen. Gold-coated glass coverslips and canti-
levers (OMCL-TR4; Olympus; nominal spring constant, ~0.02N m-1) were immersed over-
night in an ethanol solution containing 1 mM 10% 16-mercaptododecahexanoic acid—90%
1-mercapto-1-undecanol (Sigma), rinsed with ethanol, and dried with N2. Substrates and can-
tilevers were then immersed for 30 min in a solution containing 10 mg ml-1 NHS and 25 mg
ml-1 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (Sigma), rinsed with ultrapure water
(ELGA LabWater), incubated with 0.1 mg ml-1 of fibrinogen for 1 h, rinsed further with PBS
buffer, and immediately used without de-wetting.
Functionalization of cantilevers with fibrinogen. Functionalized tips were obtained
using PEG-benzaldehyde linkers [62]. Prior to functionalization, cantilevers were washed with
chloroform and ethanol, placed in a UV-ozone cleaner for 30 min, immersed overnight in an
ethanolamine solution (3.3 g ethanolamine–6 ml dimethyl sulfoxide [DMSO]), and then
washed 3 times with DMSO and 2 times with ethanol and dried with N2. The ethanolamine-
coated cantilevers were immersed for 2 h in a solution prepared by mixing 1 mg Acetal–PEG–
NHS dissolved in 0.5 ml of chloroform with 10 μl triethylamine and then washed with chloro-
form and dried with N2. Cantilevers were further immersed for 5 min in a 1% citric acid solu-
tion, washed in Ultrapure water (ELGA LabWater), and then covered with a 200 μl droplet of
PBS solution containing 200 μg ml-1 of the fibrinogen to which 2 μl of a 1 M NaCNBH3 solution
was added. After 50 min, cantilevers were incubated with 5 μl of a 1 M ethanolamine solution in
order to passivate unreacted aldehyde groups and then washed with and stored in buffer.
Single-cell force spectroscopy. For all atomic force microscopy (AFM) experiments, cells
expressing chimeric SpsL A+SD were harvested after overnight incubation, washed in PBS,
and diluted 1:100 in PBS. For SCFS, bacterial cell probes were obtained as previously described
[63, 64]. Briefly, colloidal probes were obtained by attaching a single silica microsphere (6.1
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mm diameter; Bangs Laboratories) with a thin layer of UV-curable glue (NOA 63; Norland
Edmund Optics) to triangle-shaped tipless cantilevers (NP-O10; Bruker) with a NanoWizard
III AFM (JPK Instruments). The cantilevers were then immersed for 1 h in Tris-buffered saline
(TBS; 50 mM Tris, 150 mM NaCl, pH 8.5) containing 4 mg ml-1 dopamine hydrochloride
(Sigma), rinsed in TBS, and used directly for cell probe preparation. The nominal spring con-
stant of the colloidal probe was determined by the thermal noise method. 50 μL of diluted bac-
terial suspension was deposited into a glass Petri dish containing fibrinogen (human and
canine) coated substrates at a distinct location within the Petri dish, and 3 ml of PBS was
added to the system. The colloidal probe was brought into contact with an isolated bacterium
and retracted to attach the bacterial cell; proper attachment of the cell on the colloidal probe
was checked using optical microscopy. Cell probes were used to measure cell–substrate inter-
action forces at room temperature, using an applied force of 250 pN, a constant approach-
retraction speed of 1 μm s–1, and a contact time of 0 ms. Data were analyzed using the Data
Processing software from JPK Instruments. Adhesion force and distance rupture histograms
were obtained by calculating the maximum adhesion force and rupture distance of the last
peak for each curve.
Single-molecule force spectroscopy. For SMFS, measurements were performed at room
temperature in PBS buffer using a Nanowizard III AFM (JPK Instruments) and oxide-sharpened
micro-fabricated Si3Ni4 cantilevers with a nominal spring constant of ~0.01 N m
−1 (MSCT)
(Microlevers; Bruker Corporation). The spring constants of the cantilevers were measured using
the thermal noise method. For the experiments, bacteria expressing chimeric SpsL A+SD were
immobilized on polystyrene substrates. Adhesion maps were obtained by recording 16 x 16
force-distance curves on areas of 500 by 500 nm2 with an applied force of 250 pN, a constant
approach and retraction speed of 1 m s-1, and a contact time of 0 ms. Adhesion force and rupture
distance histograms were obtained by calculating the force and rupture distance of the last peak
for each curve. Data were analyzed with the data processing software from JPK Instruments.
Canine fibrinogen α-chain sequence analysis
Genomic DNA was isolated from whole canine blood using the method described previously [65].
The region of interest in the fibrinogen α-chain was amplified using Q5 Hot Start high-fidelity
DNA polymerase (NEB) and purified using Monarch PCR & DNA Cleanup kit (NEB). Purified
PCR products were analyzed by Sanger sequencing (Eurofins) and DNAStar SeqMan Pro 14
(Lasergene). Sequence alignment was performed using MegAlign (Lasergene) and PRALINE [66].
Biofilm assay
Biofilm assays were performed using S. pseudintermedius strains expressing pALC2073 con-
structs of full length SpsL or A-domain+SD. Strains were grown in TSB supplemented with
0.5% (v/v) glucose and 3% (v/v) NaCl. 96-well tissue culture plates were coated overnight at
4˚C with 100 nM bovine, canine, human, or ovine fibrinogen with some wells left uncoated.
Overnight cultures were diluted to an OD600nm of 0.05 and 100 μl applied to the plate and
incubated at 37˚C for 24 h. The plates were washed three times with PBS and the bacteria fixed
with 25% (v/v) formaldehyde (Sigma) for 30 min. After washing, the plates were stained with
0.5% (v/v) crystal violet (Sigma) for 3 min and then solubilized with 5% acetic acid (v/v). Plates
were analyzed using a Synergy HT plate reader (BioTek) at 595 nm wavelength.
Neutrophil phagocytosis by flow cytometry
50 ml of venous blood was drawn from healthy volunteers and mixed with 6 ml of acid-citrate-
dextran (Sigma). Human neutrophils were isolated as outlined previously [67] and suspended
Bacterial host-specialized fibrinogen-binding
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007816 June 19, 2019 18 / 24
to a final concentration of 2.5 x 106 cells ml-1 in RPMI-1640 (Gibco) containing 0.05% human
serum albumin (Sigma). 2.5 x 106 CFU of bacteria, previously labelled with FITC using a
method previously described [68], were opsonized with 50 nM of extracellular matrix protein
at 37˚C for 15 min and diluted to 1 ml in RPMI-1640 containing 0.05% human serum albu-
min. 2.5 x 105 CFU were then opsonized with 10% human serum in 2 ml 96-well v-bottomed
plates (Corning) at 37˚C for 15 min. 2.5 x 105 neutrophils were added to the opsonized bacteria
(MOI of 1) and incubated at 37˚C for 15 min with shaking at 750 rpm. The samples were fixed
with 1% (v/v) paraformaldehyde (Fisher Scientific) and incubated at 4˚C for at least 30 min.
Phagocytosis was measured in comparison to serum-only controls using the BD LSRFortessa
X20 cell analyzer.
Statistical analysis
Data is presented in Prism 6 (Graphpad) with statistical analysis performed using Minitab 16.
All data was analyzed for normality, using the Anderson-Darling test, and equal variance
before choosing the method of statistical analysis. Multiple comparisons were performed were
appropriate. ELISA-type binding assays and bacterial adherence assays were analyzed at one
protein concentration. For data displaying statistical significance, the following symbols are
used, � p�0.05, �� p�0.01, and ��� p�0.001.
Supporting information
S1 Fig. Recombinant truncates of SpsL do not adhere to fibrinogen. (A) Schematic of the
SpsL recombinant truncates generated in this study. Adherence of recombinant proteins
purified from E. coli to (B) canine or (C) human fibrinogen coated at 20 μg ml-1. (D) Adher-
ence of canine fibrinogen to SpsL recombinant truncates purified from E. coli and coated at
10 μM. (E) Adherence of recombinant proteins purified from E. coli to fibronectin coated at
10 μg ml-1. (F) Adherence of recombinant proteins purified from S. pseudintermedius superna-
tant to canine fibrinogen coated at 10 μg ml-1. Binding of recombinant proteins was detected
using 0.1 μg ml-1 mouse anti-His IgG-HRP. (G) Adherence of S. aureus SH1000ΔclfAΔclfBΔfn-
bAΔfnbB expressing ClfB or SpsL to canine fibrinogen as quantified by crystal violet staining.
All data points represent the mean ± SD (n = 9).
(TIF)
S2 Fig. Generation of the SpsLΔlatch expression construct. (A) Structural model of the
N2N3 subdomains of SpsL produced in Phyre2 based on pdb 1N67. The model was annotated
in PyMol. Residues identified to be important for ClfA adherence to fibrinogen are colored in
orange with the predicted binding motif colored yellow and the predicted latch region
(502NSASGSG508) colored in blue. (B) Western blot analysis of cell wall-associated samples of
ED99ΔspsLΔspsD expressing full length SpsL or SpsLΔlatch with a predicted molecular weight
of 103 kDa. Expression was detected using 1 μg ml-1 chicken anti-SpsL N2N3 IgY and 0.5 μg
ml-1 F(ab’)2 rabbit anti-chicken IgG-HRP. The cross-reactive band present in all samples
below 55 kDa is thought to be the S. pseudintermedius antibody-binding protein SpsQ.
(TIF)
S3 Fig. Adherence of ClfB to the α-chain recombinant fragments and adherence of SpsL to
multiple sites in the tandem repeat region. (A, B) Adherence of ClfB expressed in
SH1000ΔclfAΔclfBΔtnbAΔfnbB to human and canine fragments or chimeric proteins. (C)
Schematic of the canine tandem repeat region of the fibrinogen α-chain. (D) Schematic of the
α-chain fragments covering the tandem repeat region generated and purified from E. coli. (E)
Adherence of SpsL expressed in ED99ΔspsLΔspsD to canine α-chain fragments. All data points
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represent the mean ± SD (n = 9). (F) Schematic of the α-chain deletion constructs. (G) Adher-
ence of SpsL expressed in ED99ΔspsLΔspsD to the canine α-chain deletion constructs. All data
points represent the mean with error bars representing SEM (n = 9).
(TIF)
S4 Fig. Sequence analysis of the SpsL fibrinogen-binding sites. (A) Sequence alignment of
region P283-E474 of the canine fibrinogen α-chain from 11 canine breeds. The heterozygous
alleles contain abbreviations of French bulldog (FB) and Labrador retriever (LR). (B) Sequence
analysis of the region S423-E474 of the fibrinogen α-chain from bovine, canine, human, and
ovine hosts. Both alignments were generated using the online MultAlin tool [69].
(TIF)
S1 Table. Strains and plasmids used in this study.
(DOCX)
S2 Table. Oligonucleotides used in this study.
(DOCX)
S1 Methods. Methodology only used in the supporting information.
(DOCX)
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